{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T06:53:55Z","timestamp":1653288835641},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Dermatol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1111\/ijd.13395","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T09:57:46Z","timestamp":1474538266000},"page":"e4-e5","source":"Crossref","is-referenced-by-count":3,"title":["Balancing the risks and benefits of prophylaxis: a reply to \u201c<i>Pneumocystis jiroveci<\/i>pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions\u201d"],"prefix":"10.1111","volume":"56","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of California Irvine; Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"10.1111\/ijd.13395-BIB0001|ijd13395-cit-0001","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ijd.13231","article-title":"Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis","volume":"55","author":"Gonzalez Santiago","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1111\/ijd.13395-BIB0002|ijd13395-cit-0002","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/ijd.13395-BIB0003|ijd13395-cit-0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaad.2009.11.588","article-title":"Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions","volume":"63","author":"Lehman","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ijd.13395-BIB0004|ijd13395-cit-0004","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2009.07.042","article-title":"Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications","volume":"62","author":"Gerhart","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ijd.13395-BIB0005|ijd13395-cit-0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2014.03.020","article-title":"Opportunistic infections in patients with pemphigus","volume":"71","author":"Leshem","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ijd.13395-BIB0006|ijd13395-cit-0006","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-4632.2010.04857.x","article-title":"Pneumocystis pneumonia in patients with immunobullous dermatoses","volume":"50","author":"Li","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1111\/ijd.13395-BIB0007|ijd13395-cit-0007","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ijd.13395-BIB0008|ijd13395-cit-0008","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"10","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ijd.13395-BIB0009|ijd13395-cit-0009","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ijd.13395-BIB0010|ijd13395-cit-0010","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.13395","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.13395","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijd.13395\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T01:31:49Z","timestamp":1625448709000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.13395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ijd.13395","archive":["Portico"],"relation":{},"ISSN":["0011-9059"],"issn-type":[{"value":"0011-9059","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}